Multi-Omics Discovery & In Vivo Validation of Novel Targets for Neurology & Oncology
Time: 3:15 pm
day: Conference Day Two
Details:
- Applying a data-driven approach to drug discovery by integrating large-scale multi-omics datasets with advanced AI/ML tools to uncover biology and discover novel therapeutic targets
- Discovery and development of SB-0110, a first-in-class small molecule for Parkinson’s disease and levodopa-induced dyskinesia
- Generating and deploying metabolomics-based models for drug discovery, demonstrating superior performance to transcriptomics in initial applications
